Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MPL Antikörper (AA 401-500) (Cy5)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch MPL in WB und FACS. Er zeigt eine Reaktivität gegenüber Human und Maus.
Produktnummer ABIN1408408

Kurzübersicht für MPL Antikörper (AA 401-500) (Cy5) (ABIN1408408)

Target

Alle MPL Antikörper anzeigen
MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))

Reaktivität

  • 60
  • 26
  • 23
  • 1
  • 1
Human, Maus

Wirt

  • 53
  • 9
  • 1
Kaninchen

Klonalität

  • 53
  • 10
Polyklonal

Konjugat

  • 26
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Dieser MPL Antikörper ist konjugiert mit Cy5

Applikation

  • 40
  • 36
  • 16
  • 13
  • 13
  • 8
  • 6
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS)
  • Bindungsspezifität

    • 31
    • 5
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 401-500

    Kreuzreaktivität

    Human, Maus

    Homologie

    Rat,Rabbit

    Aufreinigung

    Purified by Protein A.

    Immunogen

    KLH conjugated synthetic peptide derived from human TPOR

    Isotyp

    IgG
  • Applikationshinweise

    FCM 1:20-100

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

    Haltbarkeit

    12 months
  • Target

    MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))

    Andere Bezeichnung

    TPOR

    Hintergrund

    Synonyms: C MPL, C-MPL, CMPL, CD110, CD 110, MPL, MPLV, Myeloprolerative leukemia protein, Myeloprolerative leukemia virus oncogene, Proto-oncogene c-Mpl, THCYT2, Thrombopoietin receptor, TPO R, TPO-R, TPOR, TPOR_HUMAN.

    Background: Thrombopoietin (TPO or THPO), also known as c-Mpl ligand (c-Mpl L), is a cytokine that plays a central role in megakaryopoiesis by influencing the development and maturation of megakaryocytes and platelet production from hematopoietic stem cells. TPO exerts its biological effects through the TPO receptor, c-Mpl. c-Mpl is a member of the cytokine receptor superfamily. Expression of c-Mpl is restricted to hematopoietic tissues and cells, such as bone marrow, spleen, fetal liver and CD34+ cells. Stimulation of c-Mpl with TPO results in the activation of the Janus tyrosine kinase family members, Tyk 2 and JAK2, which in turn phosphorylate Stat5 and Stat3, causing their nuclear translocation and the transcription of Stat responsive genes. Muta-tions in c-Mpl have been implicated as the cause of certain human disorders, including congenital amegakaryocytic thrombocytopenia (CAMT) and thrombocytopenia with absent radii (TAR) syndrome.

    Pathways

    JAK-STAT Signalweg
Sie sind hier:
Chat with us!